PLEXIUM Trademark

Trademark Overview

On Friday, November 1, 2019, a trademark application was filed for PLEXIUM with the United States Patent and Trademark Office. The USPTO has given the PLEXIUM trademark a serial number of 88677119. The federal status of this trademark filing is REGISTERED as of Tuesday, June 21, 2022. This trademark is owned by Plexium, Inc.. The PLEXIUM trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development
plexium

General Information

Serial Number88677119
Word MarkPLEXIUM
Filing DateFriday, November 1, 2019
Status700 - REGISTERED
Status DateTuesday, June 21, 2022
Registration Number6768577
Registration DateTuesday, June 21, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 14, 2021

Trademark Statements

Goods and ServicesPharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, November 6, 2019
Primary Code042
First Use Anywhere DateThursday, December 31, 2020
First Use In Commerce DateThursday, December 31, 2020

Trademark Owner History

Party NamePlexium, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NamePlexium, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NamePlexium, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Tuesday, June 21, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 21, 2022REGISTERED-PRINCIPAL REGISTER
Friday, May 20, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, May 19, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, May 19, 2022STATEMENT OF USE PROCESSING COMPLETE
Monday, May 9, 2022USE AMENDMENT FILED
Thursday, May 19, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, May 9, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, November 9, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 14, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 14, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 14, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 14, 2021PUBLISHED FOR OPPOSITION
Thursday, August 26, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 26, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 26, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, August 6, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, February 6, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, August 6, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, February 6, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, February 6, 2020LETTER OF SUSPENSION E-MAILED
Thursday, February 6, 2020SUSPENSION LETTER WRITTEN
Thursday, February 6, 2020ASSIGNED TO EXAMINER
Wednesday, November 6, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, November 5, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

plexium development research pharmaceutical